Reiley Pharmaceuticals, Inc. — Form D
Reiley Pharmaceuticals, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2024-06-05. The offering totals $247K, of which $98K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2024-06-05
- Form: D
- Accession: 0001616308-24-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $247K
- Amount sold: $98K
- Remaining: $149K
- Minimum investment: $3K
- Investors: 6
- Date of first sale: 2024-05-31
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-515144
Issuer
- Name: Reiley Pharmaceuticals, Inc.
- CIK: 0001616308
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 3749 BUCHANAN STREET, SAN FRANCISCO, CA, 94147
- Phone: 650 269-8044
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Jeffrey Michael Dunn | Director | San Francisco, CA |
| Donald Michael Kiepert | Director | San Francisco, CA |
| B. Michael Silber | Director | San Francisco, CA |
| Keith Michael Valentine | Director | San Francisco, CA |
| Donald Michael Kiepert | Executive Officer | San Francisco, CA |
| B. Michael Silber | Executive Officer | San Francisco, CA |
| Mark Michael Reiley | Promoter | Washington, DC |
| Jeff Michael Dunn | Director | Santa Clara, CA |
| B Michael Silber | Executive Officer | San Francisco, CA |
Other filings by this issuer (7)
More